AVEO Pharmaceuticals, Inc. (AVEO) stock prices updated...
 

AVEO Pharmaceuticals, Inc. stock price

AVEO Pharmaceuticals, Inc. latest news:


  • 10/05/2017 15:36:16

    BRIEF-Aveo Pharmaceuticals- Tivo-3 study will continue as planned without modification

    * Aveo Pharmaceuticals Inc - ‍announces completion of Tivo-3 study futility analysis with no changes to study protocol​

  • 08/28/2017 07:51:27

    AVEO Pharma stock rises 6% after cancer drug gets approved in Europe

    AVEO Pharmaceuticals Inc. shares rose as much as 6.2% to $4.01 in extremely heavy morning trade Monday after the company's cancer drug was approved in Europe. The drug, Fotivda, was approved for adults with advanced renal cell carcinoma -- the most common type of kidney cancer -- in the European Union as well as Norway and Iceland. Fotivda is being licensed in Europe by Jazz Pharmaceuticals' EUSA Pharma Inc. The drug was recommended for approval by a scientific committee of the European Medicines Agency in late June, news that sent AVEO Pharma shares surging. AVEO Pharma shares have risen 426% over the last three months, compared with a 1.3% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Aviat Networks, Inc.AVNW | Avid Technology, Inc.AVID | Avinger, Inc.AVGR | Avis Budget Group, Inc.CAR | Aware, Inc.AWRE | Axcelis Technologies, Inc.ACLS | Axion Power International, Inc.AXPW | Axion Power International, Inc.AXPWW | AxoGen, Inc.AXGN | AXT IncAXTI |